Prodeon Medical Receives FDA 510(k) Clearance for the Urocross(R) Expander System, a Novel Non-Permanent Retrievable Implant for Treating Urinary Symptoms Associated with ...

Prodeon Medical, a privately held medical device company focused on advancing minimally invasive therapies for urologic diseases, today announced it has received U.S. Food and Drug Administration (FDA ...
Medical Device Network on MSN

Prodeon Medical’s BPH implant gains FDA clearance

In data supporting FDA approval, 48.1% implanted with Prodeon’s Urocross saw International Prostate Symptom Score ...

Remote robot surgery removes cancer 1,500 miles away

UK surgeons remotely removed a man’s prostate cancer from 1,500 miles away in the country’s first successful robot-assisted ...
Business Insider

The Uniqueness of Dr Allen’s Devices for Prostate, Kidneys and Low Back Pain Treatment Unveiled Worldwide

Oxford, UK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Topical summits in Dubai, Berlin, Nanjing, Basel, Lisbon, London and other cities discussed the uniqueness of Dr Allen's Devices, a new revolutionary ...
New York Post

Prostate cancer tumors have more than twice as much of this pollutant as healthy tissue: study

This week, cancer researchers in New York are one step closer to answering a question that has plagued medical and environmental advocates for decades: What is the role of plastic exposure in the ...
Medical Xpress

Recurrent prostate cancer: Two treatment strategies with uncertain outcomes compared

Imperial College London investigators compared focal therapy with prostate removal surgery for men with prostate cancer that returned after radiotherapy. Matched analyses estimated 10-year ...